FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Aripiprazole (Abilify)
Status: Discontinuation
»Therapeutic Categories: Psychiatry

Expand all

Otsuka Pharmaceutical Company, Ltd. (New 12/09/2014)

Company Contact Information:
800-438-6055

Presentation Posting Date Related Information
Abilify® (aripiprazole) Oral Solution 1mg/mL (NDC No. 59148-013-15) 12/09/2014 Estimated product availability until: 5/15/2015. The product discontinuation is not related to product safety or efficacy.
Abilify DISCMELT® (aripiprazole) Orally Disintegrating Tablets 10 mg (NDC No. 59148-640-23) 12/09/2014 Estimated product availbility until: 10 mg - 7/15/2015. The product discontinuation is not related to product safety or efficacy.
Abilify DISCMELT® (aripiprazole) Orally Disintegrating Tablet 15 mg (NDC No. 59148-641-23) 12/09/2014 Estimated product availability until: 15 mg - 11/30/2015. The product discontinuation is not related to product safety or efficacy.
Abilify® (aripiprazole) Injection for Intramuscular use only, 9.75 mg/1.3mL (7.5mg/mL) (NDC No. 59148-016-65) 12/09/2014 Estimated product availability until 6/15/2015. The product discontinuation is not related to product safety or efficacy.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English